120 related articles for article (PubMed ID: 25873927)
1. Association of mild kidney dysfunction with silent brain lesions in neurologically normal subjects.
Toyoda G; Bokura H; Mitaki S; Onoda K; Oguro H; Nagai A; Yamaguchi S
Cerebrovasc Dis Extra; 2015; 5(1):22-7. PubMed ID: 25873927
[TBL] [Abstract][Full Text] [Related]
2. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly.
Wada M; Nagasawa H; Iseki C; Takahashi Y; Sato H; Arawaka S; Kawanami T; Kurita K; Daimon M; Kato T
J Neurol Sci; 2008 Sep; 272(1-2):36-42. PubMed ID: 18541269
[TBL] [Abstract][Full Text] [Related]
3. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.
Martinez-Vea A; Salvadó E; Bardají A; Gutierrez C; Ramos A; García C; Compte T; Peralta C; Broch M; Pastor R; Angelet P; Marcas L; Saurí A; Oliver JA
Am J Kidney Dis; 2006 Feb; 47(2):241-50. PubMed ID: 16431253
[TBL] [Abstract][Full Text] [Related]
4. Subclinical cerebral abnormalities in chronic kidney disease.
Yao H; Takashima Y; Hashimoto M; Uchino A; Yuzuriha T
Contrib Nephrol; 2013; 179():24-34. PubMed ID: 23652446
[TBL] [Abstract][Full Text] [Related]
5. Sleep Duration, Kidney Function, and Their Effects on Cerebral Small Vessel Disease in Elderly Hypertensive Patients.
Nagai M; Hoshide S; Takahashi M; Shimpo M; Kario K
Am J Hypertens; 2015 Jul; 28(7):884-93. PubMed ID: 25559119
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome is associated with silent ischemic brain lesions.
Bokura H; Yamaguchi S; Iijima K; Nagai A; Oguro H
Stroke; 2008 May; 39(5):1607-9. PubMed ID: 18323475
[TBL] [Abstract][Full Text] [Related]
7. Subcortical silent brain infarction as a risk factor for clinical stroke.
Kobayashi S; Okada K; Koide H; Bokura H; Yamaguchi S
Stroke; 1997 Oct; 28(10):1932-9. PubMed ID: 9341698
[TBL] [Abstract][Full Text] [Related]
8. Decreased kidney function is a significant factor associated with silent cerebral infarction and periventricular hyperintensities.
Shima H; Ishimura E; Naganuma T; Ichii M; Yamasaki T; Mori K; Nakatani T; Inaba M
Kidney Blood Press Res; 2011; 34(6):430-8. PubMed ID: 21709424
[TBL] [Abstract][Full Text] [Related]
9. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study.
Vermeer SE; Hollander M; van Dijk EJ; Hofman A; Koudstaal PJ; Breteler MM;
Stroke; 2003 May; 34(5):1126-9. PubMed ID: 12690219
[TBL] [Abstract][Full Text] [Related]
10. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study.
Bokura H; Kobayashi S; Yamaguchi S; Iijima K; Nagai A; Toyoda G; Oguro H; Takahashi K
J Stroke Cerebrovasc Dis; 2006; 15(2):57-63. PubMed ID: 17904049
[TBL] [Abstract][Full Text] [Related]
11. Cerebral microbleeds in predialysis patients with chronic kidney disease.
Shima H; Ishimura E; Naganuma T; Yamazaki T; Kobayashi I; Shidara K; Mori K; Takemoto Y; Shoji T; Inaba M; Okamura M; Nakatani T; Nishizawa Y
Nephrol Dial Transplant; 2010 May; 25(5):1554-9. PubMed ID: 20037183
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal relationship between chronic kidney disease and distribution of cerebral microbleeds in patients with ischemic stroke.
Peng Q; Sun W; Liu W; Liu R; Huang Y;
J Neurol Sci; 2016 Mar; 362():1-6. PubMed ID: 26944109
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease, 24-h blood pressure and small vessel diseases are independently associated with cognitive impairment in lacunar infarct patients.
Yamamoto Y; Ohara T; Nagakane Y; Tanaka E; Morii F; Koizumi T; Akiguchi I
Hypertens Res; 2011 Dec; 34(12):1276-82. PubMed ID: 21832998
[TBL] [Abstract][Full Text] [Related]
14. Mild chronic kidney disease and functional impairment in community-dwelling older adults.
Smyth A; Glynn LG; Murphy AW; Mulqueen J; Canavan M; Reddan DN; O'Donnell M
Age Ageing; 2013 Jul; 42(4):488-94. PubMed ID: 23438445
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and risk factor analysis of silent brain infarction in patients with first-ever ischemic stroke.
Oh SH; Kim NK; Kim SH; Kim JK; Kim HS; Kim WC; Kim OJ
J Neurol Sci; 2010 Jun; 293(1-2):97-101. PubMed ID: 20356606
[TBL] [Abstract][Full Text] [Related]
16. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
17. Cerebrorenal interaction and stroke.
Toyoda K
Contrib Nephrol; 2013; 179():1-6. PubMed ID: 23676853
[TBL] [Abstract][Full Text] [Related]
18. Adults with late stage 3 chronic kidney disease are at high risk for prevalent silent brain infarction: a population-based study.
Chou CC; Lien LM; Chen WH; Wu MS; Lin SM; Chiu HC; Chiou HY; Bai CH
Stroke; 2011 Aug; 42(8):2120-5. PubMed ID: 21700935
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients.
Tsai JC; Chen SC; Hwang SJ; Chang JM; Lin MY; Chen HC
Am J Kidney Dis; 2010 May; 55(5):856-66. PubMed ID: 20153917
[TBL] [Abstract][Full Text] [Related]
20. Influence of adrenomedullin 2/intermedin gene polymorphism on blood pressure, renal function and silent cerebrovascular lesions in Japanese: the Ohasama study.
Hirose T; Totsune K; Nakashige Y; Metoki H; Kikuya M; Ohkubo T; Hara A; Satoh M; Inoue R; Asayama K; Kondo T; Kamide K; Katsuya T; Ogihara T; Izumi S; Rakugi H; Takahashi K; Imai Y
Hypertens Res; 2011 Dec; 34(12):1327-32. PubMed ID: 21832999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
